Medtronic reported $37.5B of revenue over the trailing twelve months, +9.8% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $37.5B (to Q1 2027). Net Income: $5.23B, trailing twelve months to Q1 2027. Free Cash Flow: $6.13B, trailing twelve months to Q1 2027. Op Margin: 18%, trailing twelve months to Q1 2027.

MDTMedtronic

HealthcareUSD

$92.40

$73.7552 weeks$103.73

On our screens:Stocks that buy back more than they dilute

MDT as reported

Medtronic reported $37.5B of revenue over the trailing twelve months, +9.8% on the year before. 11 reported series are charted on this page, each one as filed.

$37.5B

Revenue, trailing twelve months · to Q1 2027 · +9.8% against the twelve months before

Net Income: $5.23B
Net Income · +12% year on year · trailing twelve months to Q1 2027
Free Cash Flow: $6.13B
Free Cash Flow · +16% year on year · trailing twelve months to Q1 2027
Op Margin: 18%
Op Margin · trailing twelve months to Q1 2027

Every series Ryufin has for MDT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$37.5B	+9.8%	Q1 2027
Net Income	$5.23B	+12%	Q1 2027
EPS	$4.07	+12%	Q1 2027
Gross Margin	65%	n/a	Q1 2027
Op Margin	18%	n/a	Q1 2027
Net Margin	14%	n/a	Q1 2027
ROE	9.8%	n/a	Q1 2027
ROA	5.3%	n/a	Q1 2027
ROIC	7.3%	n/a	Q1 2027
Free Cash Flow	$6.13B	+16%	Q1 2027
P/E	22.7	n/a	today